Details for: COUGH SYRUP WITH CODEINE
Company: TEVA CANADA LIMITED
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02099748 | COUGH SYRUP WITH CODEINE | CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; GUAIFENESIN | 3.3 MG / 5 ML; 30 MG / 5 ML; 100 MG / 5 ML | SYRUP | ORAL |
Summary Reports
Summary Safety Review - Codeine-containing products - Further Assessing the Risk of Serious Breathing Problems in Children and Adolescents
Summary Safety Review - CODEINE PRESCRIPTION PRODUCTS Indicated for Cough - Further Assessing the Risk of Serious Breathing Problems in Children and Adolescents
Summary Safety Review - Over-the-Counter Products Containing Pseudoephedrine - Assessing the Potential Risk of Inflammation and Injury of the Large Intestine due to Insufficient Blood Supply (ischemic colitis)
Summary Safety Review -Opioid-containing cough and cold products - Assessing the potential risk of opioid use disorder and related harms in children and adolescents
Summary Safety Review - CODEINE PRESCRIPTION PRODUCTS Indicated for Cough - Further Assessing the Risk of Serious Breathing Problems in Children and Adolescents
Summary Safety Review - Over-the-Counter Products Containing Pseudoephedrine - Assessing the Potential Risk of Inflammation and Injury of the Large Intestine due to Insufficient Blood Supply (ischemic colitis)
Summary Safety Review -Opioid-containing cough and cold products - Assessing the potential risk of opioid use disorder and related harms in children and adolescents
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.